11 Charts That Matter
Special write-up on Recursion (RXRX)
This week we cover:
RXRX
ARM
AMD
ASML
META
Tencent
Copper
Coupang
India hurting
Follow us @gmgresearch.
Recursion Pharmaceuticals (RXRX): Our original readers know that this has been on our radar for some time now. In partnership with NVIDIA, Recursion Pharmaceuticals has developed the most powerful supercomputer in biopharma, with plans to launch an even more powerful system, BioHive-2, at 23.3 petaflops. Jansen, CEO of Nvidia, praised the collaboration: ““If I were to start from nothing, I would do it the way Recursion does it. The systematic way of generating data. I think it's an excellent method, which is the reason why Nvidia is an investor… Even if the world had enough data on human biology, I would still pursue Recursion's systematic approach.” (Minute 17:55). He concluded with a strong endorsement of the partnership's future impact on drug discovery: “We (Nvidia) deeply believe that this is going to be the future of the way that drugs will be discovered and designed.” Click Here For Video
ARM down 30%+ from highs is starting to look great.
A pair trader’s paradise.
India: Still underperforming the S&P in this rally. India will continue to be weak.
AMD: Oversold but not for long.
Tencent: Good follow through from two weeks ago.
Copper looking toppy.
Coupang! is starting to take a pause but still a strong uptrend.
ASML: $775 doesn’t look likely. Look to add on weakness.
META: As we highlighted after earnings, this gap down was a gift.
Once again, Counter Strike skins are going parabolic. Some are up hundreds of percent in 2 months. Liquid market.
Return always wants its risk payment.
NOT INVESTMENT ADVICE. Only for entertainment.